Allergan Inc. v Sandoz Canada Inc. et al.
2018
T-2023-18
Resolved
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,507,002 and 2,496,780 (silodosin)
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team
![Carol Hitchman](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0b350718f350133b0bea2_carol-website-bw-min.jpg)
Carol Hitchman
Counsel
![Meghan A. Dureen, Ph.D.](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0bae05e71cd3af89ae952_meghan-bw-min.jpeg)
Meghan A. Dureen, Ph.D.
Counsel